从布洛芬衍生的硫代氨基脲和1,2,4-三唑作为MetAP (II型)抑制剂的设计和合成

IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Özgür Yılmaz , Yağmur Biliz , Sümeyra Ayan , Özge Çevik , Müfide Karahasanoğlu , Reyhan Çotuker , Naz Mina Mert Şahin , Kübra Gökkaya , Sevgi Gülyüz , Kemal Yelekçi , Ş. Güniz Küçükgüzel
{"title":"从布洛芬衍生的硫代氨基脲和1,2,4-三唑作为MetAP (II型)抑制剂的设计和合成","authors":"Özgür Yılmaz ,&nbsp;Yağmur Biliz ,&nbsp;Sümeyra Ayan ,&nbsp;Özge Çevik ,&nbsp;Müfide Karahasanoğlu ,&nbsp;Reyhan Çotuker ,&nbsp;Naz Mina Mert Şahin ,&nbsp;Kübra Gökkaya ,&nbsp;Sevgi Gülyüz ,&nbsp;Kemal Yelekçi ,&nbsp;Ş. Güniz Küçükgüzel","doi":"10.1016/j.cbi.2025.111555","DOIUrl":null,"url":null,"abstract":"<div><div>In the present study, a range of novel thiosemicarbazides <strong>4a-i</strong> and 1,2,4-triazoles <strong>5a-i</strong> derived from ibuprofen, were synthesized. Structural elucidation of these synthesized compounds was performed utilizing a variety of spectroscopic methods, including FTIR, <sup>1</sup>H NMR, <sup>13</sup>C NMR and HR-MS. The synthesized compounds were tested for cytotoxicity in five different cancer cell lines (cervical cancer (HeLa), human breast cancer (MCF-7), human gastric adenocarcinoma (MKN-45), human metastatic prostate cancer (PC3) and human glioblastoma (U87)). The compounds were compared with healthy cells (NIH-3T3) and the most effective compounds were determined by means of the selectivity index. Thiosemicarbazides derived form ibuprofen <strong>4i</strong> and <strong>4d</strong> showed anticancer activity, while 1,2,4-triazoles derived form ibuprofen <strong>5b, 5c, 5d, 5e, 5h, 5g</strong> showed anticancer activity in HeLa, MCF-7, MKN-45, PC3 and U87 cells. To test the stability of the protein-drug complexes all 18 compounds <strong>4a-i</strong> and <strong>5a-i</strong> were docked into the active site of the MetAP2 enzyme In general, computational inhibition constants values were correlated with the experimental values. The dynamic behavior of MetAP2-inhibitor complexes was analyzed using all atoms Molecular Dynamic (MD) simulations for 200 ns duration. MD revealed that the drugs bind in the active center of MetAP2 with stable RMSD and RMSF. In conclusion, in-silico results and in-vitro studies suggests that thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen may be novel anticancer drug candidates for treating cervical, breast, prostate, gastric and glioblastoma. Compounds provided induction of apoptotic proteins in the cell by inhibiting MetAP2 enzyme. Furthermore, the potential antioxidant activities of the compounds were evaluated using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity assay. Among the compounds tested, <strong>4a</strong>, <strong>4b</strong>, <strong>4e</strong>, <strong>4f</strong>, <strong>4h</strong>, and <strong>4i</strong> exhibited values closely resembling the DPPH activity of the standards.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"416 ","pages":"Article 111555"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design and synthesis of thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen as potential MetAP (type II) inhibitors\",\"authors\":\"Özgür Yılmaz ,&nbsp;Yağmur Biliz ,&nbsp;Sümeyra Ayan ,&nbsp;Özge Çevik ,&nbsp;Müfide Karahasanoğlu ,&nbsp;Reyhan Çotuker ,&nbsp;Naz Mina Mert Şahin ,&nbsp;Kübra Gökkaya ,&nbsp;Sevgi Gülyüz ,&nbsp;Kemal Yelekçi ,&nbsp;Ş. Güniz Küçükgüzel\",\"doi\":\"10.1016/j.cbi.2025.111555\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In the present study, a range of novel thiosemicarbazides <strong>4a-i</strong> and 1,2,4-triazoles <strong>5a-i</strong> derived from ibuprofen, were synthesized. Structural elucidation of these synthesized compounds was performed utilizing a variety of spectroscopic methods, including FTIR, <sup>1</sup>H NMR, <sup>13</sup>C NMR and HR-MS. The synthesized compounds were tested for cytotoxicity in five different cancer cell lines (cervical cancer (HeLa), human breast cancer (MCF-7), human gastric adenocarcinoma (MKN-45), human metastatic prostate cancer (PC3) and human glioblastoma (U87)). The compounds were compared with healthy cells (NIH-3T3) and the most effective compounds were determined by means of the selectivity index. Thiosemicarbazides derived form ibuprofen <strong>4i</strong> and <strong>4d</strong> showed anticancer activity, while 1,2,4-triazoles derived form ibuprofen <strong>5b, 5c, 5d, 5e, 5h, 5g</strong> showed anticancer activity in HeLa, MCF-7, MKN-45, PC3 and U87 cells. To test the stability of the protein-drug complexes all 18 compounds <strong>4a-i</strong> and <strong>5a-i</strong> were docked into the active site of the MetAP2 enzyme In general, computational inhibition constants values were correlated with the experimental values. The dynamic behavior of MetAP2-inhibitor complexes was analyzed using all atoms Molecular Dynamic (MD) simulations for 200 ns duration. MD revealed that the drugs bind in the active center of MetAP2 with stable RMSD and RMSF. In conclusion, in-silico results and in-vitro studies suggests that thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen may be novel anticancer drug candidates for treating cervical, breast, prostate, gastric and glioblastoma. Compounds provided induction of apoptotic proteins in the cell by inhibiting MetAP2 enzyme. Furthermore, the potential antioxidant activities of the compounds were evaluated using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity assay. Among the compounds tested, <strong>4a</strong>, <strong>4b</strong>, <strong>4e</strong>, <strong>4f</strong>, <strong>4h</strong>, and <strong>4i</strong> exhibited values closely resembling the DPPH activity of the standards.</div></div>\",\"PeriodicalId\":274,\"journal\":{\"name\":\"Chemico-Biological Interactions\",\"volume\":\"416 \",\"pages\":\"Article 111555\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-05-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemico-Biological Interactions\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009279725001851\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemico-Biological Interactions","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009279725001851","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究合成了一系列由布洛芬衍生的新型硫代氨基脲类化合物4a-i和1,2,4-三唑类化合物5a-i。利用FTIR、1H NMR、13C NMR和HR-MS等多种光谱方法对合成的化合物进行了结构分析。合成的化合物在5种不同的癌细胞系(宫颈癌(HeLa)、人乳腺癌(MCF-7)、人胃腺癌(MKN-45)、人转移性前列腺癌(PC3)和人胶质母细胞瘤(U87))中进行了细胞毒性试验。将化合物与健康细胞(NIH-3T3)进行比较,通过选择性指数确定最有效的化合物。由布洛芬4i和4d衍生的硫代氨基脲类化合物对HeLa、MCF-7、MKN-45、PC3和U87细胞具有抗癌活性,而由布洛芬5b、5c、5d、5e、5h、5g衍生的1,2,4-三唑类化合物对细胞具有抗癌活性。为了测试蛋白-药物复合物的稳定性,所有18种化合物4a-i和5a-i都停靠在MetAP2酶的活性位点上。总的来说,计算抑制常数值与实验值相关。利用全原子分子动力学(MD)模拟分析了metap2 -抑制剂配合物在200 ns持续时间内的动力学行为。MD显示药物结合在MetAP2的活性中心,RMSD和RMSF稳定。总之,计算机实验结果和体外研究表明,从布洛芬中提取的硫代氨基脲和1,2,4-三唑可能是治疗宫颈癌、乳腺癌、前列腺癌、胃癌和胶质母细胞瘤的新型候选抗癌药物。化合物通过抑制MetAP2酶诱导细胞凋亡蛋白。此外,通过2,2-二苯基-1-苦味酰肼(DPPH)自由基清除活性测定,评价了化合物的潜在抗氧化活性。在所测化合物中,4a、4b、4e、4f、4h和4i的DPPH活性值与标准值非常接近。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Design and synthesis of thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen as potential MetAP (type II) inhibitors

Design and synthesis of thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen as potential MetAP (type II) inhibitors
In the present study, a range of novel thiosemicarbazides 4a-i and 1,2,4-triazoles 5a-i derived from ibuprofen, were synthesized. Structural elucidation of these synthesized compounds was performed utilizing a variety of spectroscopic methods, including FTIR, 1H NMR, 13C NMR and HR-MS. The synthesized compounds were tested for cytotoxicity in five different cancer cell lines (cervical cancer (HeLa), human breast cancer (MCF-7), human gastric adenocarcinoma (MKN-45), human metastatic prostate cancer (PC3) and human glioblastoma (U87)). The compounds were compared with healthy cells (NIH-3T3) and the most effective compounds were determined by means of the selectivity index. Thiosemicarbazides derived form ibuprofen 4i and 4d showed anticancer activity, while 1,2,4-triazoles derived form ibuprofen 5b, 5c, 5d, 5e, 5h, 5g showed anticancer activity in HeLa, MCF-7, MKN-45, PC3 and U87 cells. To test the stability of the protein-drug complexes all 18 compounds 4a-i and 5a-i were docked into the active site of the MetAP2 enzyme In general, computational inhibition constants values were correlated with the experimental values. The dynamic behavior of MetAP2-inhibitor complexes was analyzed using all atoms Molecular Dynamic (MD) simulations for 200 ns duration. MD revealed that the drugs bind in the active center of MetAP2 with stable RMSD and RMSF. In conclusion, in-silico results and in-vitro studies suggests that thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen may be novel anticancer drug candidates for treating cervical, breast, prostate, gastric and glioblastoma. Compounds provided induction of apoptotic proteins in the cell by inhibiting MetAP2 enzyme. Furthermore, the potential antioxidant activities of the compounds were evaluated using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity assay. Among the compounds tested, 4a, 4b, 4e, 4f, 4h, and 4i exhibited values closely resembling the DPPH activity of the standards.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.70
自引率
3.90%
发文量
410
审稿时长
36 days
期刊介绍: Chemico-Biological Interactions publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信